Article Information
History
- November 2, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ilona Nln1,
- Ruth Fernandez-Ruiz1,
- Theresa L. Wampler Muskardin1,
- Jacqueline L. Paredes1,
- Ashira D. Blazer1,
- Stephanie Tuminello2,
- Mukundan Attur3,
- Eduardo Iturrate4,
- Christopher M. Petrilli4,
- Steven B. Abramson4,
- Aravinda Chakravarti2 and
- Timothy B. Niewold1,*
- 1Colton Center for Autoimmunity, NYU Grossman School of Medicine, New York, NY
- 2Center for Human Genetics and Genomics, NYU Grossman School of Medicine, New York, NY
- 3Divison of Rheumatology, Department of Medicine, NYU Grossman School of Medicine, New York, NY
- 4Department of Medicine, NYU Grossman School of Medicine, New York, NY
- ↵*Correspondence:
Timothy Niewold MD, Colton Center for Autoimmunity, NYU Grossman School of Medicine, 550 1st Ave., New York, NY 10016. Phone: 646 501 8255. Email: Timothy.Niewold{at}nyulangone.org
Posted November 02, 2021.
Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19
